Compared to the pulmonary histopathology of PAH patients with bone morphogenetic protein receptor type 2 (BMPR2) mutation who also survived for a long time and died incidentally, most pathological manifestations in CCB responders reported in this study were mild illness lesions, even in cases with a very long survival period. Here, BMPR2 is linked to pulmonary arterial hypertension.